Shifting the commercial model toward recurring and utilization-based revenue streams, primarily through the expansion of the Fair Deal Agreement (FDA) program and system rentals.

Expected impact: Builds long-term revenue predictability and expands the customer base, though it creates near-term gross margin and revenue timing pressures.

Deploying Sensus Link, a point-of-care cloud-based software and connectivity solution, to the SRT-100 installed base to provide enhanced workflow, treatment documentation, and operating intelligence.

Expected impact: Establishes a scalable, high-margin recurring revenue stream tied to treatment workflows and physics oversight services.

Partnering with third-party banks to offer flexible financing and leasing alternatives to simplify system acquisition for independent medical practices and corporate accounts.

Expected impact: Improves conversion of purchase-oriented prospects by lowering administrative barriers and reducing the practice breakeven threshold.

Expanding the direct sales force and targeting independent practices, group networks, and hospitals to reduce historical customer concentration.

Expected impact: Reduces reliance on the historically largest customer (which represented 52% of 2025 revenue) and drives direct sales under the new reimbursement environment.